R&D

Gilead to lean on Second Genome's microbiome work in $38M research pact
BioPharma Dive
Mon, 04/6/20 - 09:31 pm
Gilead Sciences
Second Genome
microbiome
R&D
Pfizer signs up for longer pact with Icon, pens extra 2-year clause
Fierce Biotech
Mon, 04/6/20 - 10:27 am
Pfizer
ICON
CROs
R&D
Servier signed a definitive agreement to acquire Symphogen, a leading antibody discovery company, to boost its antibody capabilities and leverage its R&D pipeline
AP
Fri, 04/3/20 - 12:27 pm
Servier
R&D
Symphogen
antibodies
Amgen teams up with Adaptive to both treat and prevent COVID-19
Fierce Biotech
Thu, 04/2/20 - 10:56 am
Amgen
Adaptive Biotechnologies
R&D
COVID-19
As Covid-19 hinders clinical trial operations, research staff are finding themselves out of work
MedCity News
Wed, 04/1/20 - 10:09 am
clinical trials
R&D
COVID-19
New FDA Program to Accelerate Coronavirus Treatments
RAPS.org
Tue, 03/31/20 - 10:11 pm
FDA
COVID-19
R&D
Lundbeck adds a Parkinson's flop to its list of setbacks, writing off a $1.1 billion deal on mid-stage failure
Endpoints
Mon, 03/30/20 - 10:47 am
Lundbeck
R&D
Parkinson's Disease
foliglurax
Biotech’s balancing act amid Covid-19 delays
EP Vantage
Fri, 03/27/20 - 12:13 am
R&D
COVID-19
biotech
Pharma giants including Novartis collaborate on COVID-19 therapies
Pharmaforum
Thu, 03/26/20 - 10:38 am
JNJ
Novartis
Boehringer Ingelheim
Biomerieux
Eisai
Eli Lilly
Gilead Sciences
GSK
Merck
Merck KGaA
Pfizer
Sanofi
R&D
COVID-19
diagnostics
vaccines
COVID-19 prompts Pfizer to stop enrollment in most studies
Fierce Pharma
Thu, 03/26/20 - 10:33 am
Pfizer
Bristol-Myers Squibb
Eli Lilly
R&D
clinical trials
COVID-19
Strategic Planning In Biotech During A Pandemic Crisis
Forbes
Thu, 03/26/20 - 10:20 am
biotech
R&D
strategic planning
COVID-19
CytomX pens $1.6B Astellas biobucks pact for T-cell R&D
Fierce Biotech
Tue, 03/24/20 - 10:22 am
Astellas
CytomX
R&D
White House Taps IBM to Fight Coronavirus Outbreak
Motley Fool
Mon, 03/23/20 - 11:43 am
White House
IBM
COVID-19
R&D
AlloVir, Baylor ally to develop COVID-19 T-cell therapy
Fierce Biotech
Mon, 03/23/20 - 11:42 am
AlloVir
Baylor
COVID-19
t-cell therapies
R&D
Bayer inks up with “small” Indian biotech for new approach at an old target
Endpoints
Mon, 03/23/20 - 11:31 am
Bayer
Curadev
Takeda
R&D
India
The bacteria-trapping protein that may provide a new target for tracking and treating breast cancer
Fierce Biotech
Sat, 03/21/20 - 12:12 am
R&D
breast cancer
PAD4
Inside Regeneron's R&D war room, sleepless nights and 'esprit de corps' in hunt for COVID-19 therapy
Fierce Pharma
Sat, 03/21/20 - 12:09 am
Regeneron
R&D
COVID-19
Kevzara
COVID-19's Impact on Life Sciences Researchers
BioSpace
Tue, 03/17/20 - 11:47 pm
R&D
COVID-19
Coronavirus pandemic forces some research labs to shut down, with uncertain futures for scientific projects
Stat
Sun, 03/15/20 - 02:06 pm
R&D
coronaviruses
COVID-19
Running Your Pharma Company Out Of A Starbucks: Drug Discovery Moves To The Cloud
Forbes
Fri, 03/13/20 - 11:11 am
drug discovery
R&D
robotics
remote work

Pages